Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Renal Cell Carcinoma (Kidney Cancer): early-phase trial registry
2 of 3 indexed Renal Cell Carcinoma (Kidney Cancer) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Renal Cell Carcinoma (Kidney Cancer): 3 US clinical trials tracked, 2 recruiting.
Renal Cell Carcinoma (Kidney Cancer) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Nimbus Saturn, running 1 of these trials.
Enrollment posture brief
Registry condition renal-cell-carcinoma-kidney-cancer
OPEN 2 | RECR 67% | LATE 0 | EARLY 3 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Renal Cell Carcinoma (Kidney Cancer) lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Renal Cell Carcinoma (Kidney Cancer) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Renal Cell Carcinoma (Kidney Cancer) is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Kura Oncology
NCT06026410
Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT07062549
A Study of NDI 1150-101 in Patients With Solid Tumors
Nimbus Saturn
NCT05128487
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Renal Cell Carcinoma (Kidney Cancer) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Renal Cell Carcinoma (Kidney Cancer) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Renal Cell Carcinoma (Kidney Cancer) page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Renal Cell Carcinoma (Kidney Cancer) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Nimbus Saturn sponsors the most Renal Cell Carcinoma (Kidney Cancer) trials on record, review their full trial history before evaluating a specific study. See Nimbus Saturn's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Renal Cell Carcinoma (Kidney Cancer) condition card totals 3 registered trials; most-linked intervention NDI-101150; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.